Brandon Nathan, MD

Associate Professor, Department of Pediatrics

Brandon Nathan

Contact Info

Office Phone 612-624-5409

Fax 612-626-5262

Mailing Address:
Pediatric Endocrinology
Academic Office Building
2450 Riverside Ave S AO-201
Minneapolis, MN 55454

Associate Professor, Department of Pediatrics

Faculty Member, Division of Pediatric Endocrinology

Pediatric Endocrinologist

MD, Dartmouth Medical School, Hanover, NH

Residency in Pediatrics, University of Wisconsin, Madison, WI

Fellowship in Pediatric Endocrinology and Metabolism, Rainbow Babies and Children's Hospital, Cleveland, OH


Brandon Nathan, MD, is an Associate Professor in the Division of Pediatric Endocrinology, and joined the division in 2006. He is a graduate of Colorado College and Dartmouth Medical School. Dr. Nathan completed his Pediatrics residency training at the University of Wisconsin (2002) and fellowship training in Endocrinology and Metabolism at Case Western Reserve University (2006). Dr. Nathan's research is focused on the care of children with type 1 diabetes. He has a particular interest in identifying high risk populations for prevention trials, and has collaborated with other prominent researchers across the country in this area. His clinical practice incorporates all aspects of Pediatric general endocrinology and diabetes mellitus. 

Awards & Recognition

  • Department Leadership Award, Department of Pediatrics, University of Minnesota (2021)
  • Minnesota Monthly “Top Doctors” (2016-2019, 2021)
  • Minneapolis - St. Paul “Top Doctors” (2012-2018, 2020, 2021)
  • Best Doctors in America® (2009-2017)
  • Clinical/Translational Paper of the Year (Associate or Full Professor), Department of Pediatrics, University of Minnesota (2017)
  • Charles C. Lobeck Medical Education Award, University of Wisconsin (2003)
  • Outstanding Resident Teacher Award, University of Wisconsin (2003)
  • Children Matter Award Recipient, University of Wisconsin (2000)


Research Summary/Interests



  • Nathann BM, Boilware D, Geyer S, Atkinson MA, Colmon P, Goland R, Russell W, Wentworth JM, Wilson DM, Evans-Molina C, Wherrett D, Skyler JS, Moran Am Sosenko JM (2017). Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials. Diabetes Care 40, 1494-1499. 



Pediatric Specialty Care-Burnsville;Pediatric Specialty Care-Woodbury

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics - Pediatric Endocrinology

Clinical Interests

Disorders of pubertal development; Thyroid disease; Disorders of growth; Hypoglycemia; Type 1 Diabetes; Type 2 Diabetes; Disorders of water metabolism

Hospital Privileges

Fairview Ridges Hospital; University of Minnesota Masonic Children's Hospital; University of Minnesota Medical Center